logo

For the Inventor, By the Inventor

Schopfheim, Germany

Arnold Trzeciak

This inventor holds 15 USPTO granted patents, plus 2 CIPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Hoffmann-La Roche Inc.. Active years: 1978-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arnold Trzeciak. Retrieved from https://idiyas.com/inventor/arnold-trzeciak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.5

ph-index = 7

Forward Citations = 213(Granted Patents)


Location History:

  • Lorrach, DE (1978)
  • Schopfheim, DE (1985 - 2000)

Company Filing History:

goldMedal15 out of 5,027 
 
Hoffmann-La Roche Inc.
 patents

Years Active: 1978-2000

Loading Chart...
Loading Chart...
Areas of Expertise:
Peptide Conjugates
Acylated Oligopeptides
Antithrombic Peptides
Carboxamides
Sulfonamides
Tetrahydronaphthalene Derivatives
Thymosin Synthesis
Tri-Cyclic Compounds
Pharmaceutical Compounds
N-terminal Amidino Moieties
Acetic Acid Derivatives
Benzoic Acid Derivatives
15 patents (USPTO):Explore Patents
1. 6030602 - Peptide conjugates for transfecting cells (2000-02-29),
2. 5811548 - Tri-and tetracyclic compounds (1998-09-22),
3. 5811389 - Tri- and tetracyclic compounds (1998-09-22),
4. 5759827 - Acylated oligopeptides for transfecting cells (1998-06-02),
5. 5663297 - Antithrombic peptides (1997-09-02),
6. 5644024 - Tetrahydronaphthalene derivatives (1997-07-01),
7. 5430024 - Peptides bearing N-terminal amidino moieties and their use as inhibitors (1995-07-04),
8. 5399585 - Carboxamides and sulfonamides compounds which have useful pharmaceutical (1995-03-21),
9. 5273982 - Acetic acid derivatives (1993-12-28),
10. 5256812 - Carboxamides and sulfonamides (1993-10-26),
11. 5084466 - Novel carboxamide pyridine compounds which have useful pharmaceutical (1992-01-28),
12. 5039805 - Novel benzoic and phenylacetic acid derivatives (1991-08-13),
13. 4517119 - Synthesis of thymosin .alpha..sub.1 (1985-05-14),
14. 4504415 - Synthesis of thymosin .alpha..sub.1 and desacetyl thymosin .alpha..sub.1 (1985-03-12),
15. 4066635 - L-Pyroglutamyl-L-histidyl-L-prolyl-beta-alaninamide and salts (1978-01-03),

Title: The Innovative Contributions of Arnold Trzeciak

Introduction

Arnold Trzeciak is a prominent inventor based in Schopfheim, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of peptide conjugates and their applications in medicine. With a total of 15 patents to his name, Trzeciak's work has the potential to impact various areas of research and therapeutic development.

Latest Patents

Among his latest patents, Trzeciak has developed peptide conjugates for transfecting cells. This invention relates to conjugates of lipids and basic, membrane disturbing peptides. Additionally, he has worked on tri- and tetracyclic compounds, which are described by specific chemical formulas. These compounds are not only useful as research tools for determining biologically active peptide sequences but also hold promise as medicaments. Some of these compounds may be beneficial in preventing or controlling the formation of blood platelet thrombi, while others serve as intermediates in various chemical processes.

Career Highlights

Trzeciak is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical and biotechnology sectors. His work at this esteemed organization has allowed him to further his research and innovation in the field of peptide technology.

Collaborations

Throughout his career, Trzeciak has collaborated with notable colleagues, including Leo Alig and Albrecht Edenhofer. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Arnold Trzeciak's innovative work in peptide conjugates and related compounds showcases his significant contributions to biotechnology. His patents reflect a commitment to advancing medical research and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…